Rapport Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
RAPP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1325 Boylston Street, Suite 401, Boston, MA

Insiders trading volume in the past year

Rapport Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures V, L.P. 10%+ Owner $80.9M Jun 10, 2024
ARCH Venture Partners XII, LLC 10%+ Owner $37.2M Jun 10, 2024
James Healy Director $19.9M Jun 17, 2025
Abraham Ceesay Chief Executive Officer, Director $17.7M -$2.57M -12.7% Nov 17, 2025
David Bredt Chief Scientific Officer $10.2M -$1.03M -9.17% Nov 17, 2025
Krishnaswamy Yeleswaram Chief Development Officer $2.9M Feb 3, 2025
Bradley S. Galer Chief Medical Officer $1.97M Jun 6, 2024
Cheryl Gault Chief Operating Officer $1.72M Sep 8, 2025
Steven M. Paul Director $416K Sep 12, 2025
Reid M. Huber Director $204K Sep 12, 2025
Troy A. Ignelzi Chief Financial Officer $99.8K +$101K Mar 12, 2025
Wendy B. Young Director $94.9K +$61.3K +182% Sep 11, 2025
Paul M. Silva Director Jun 17, 2025
John Maraganore Director Jun 17, 2025
Jeffrey K. Tong Director Jun 6, 2024
Robert J. Perez Director Jun 17, 2025
Terry-Ann Burrell Director Jun 6, 2024
Jeffrey Sevigny Chief Medical Officer Apr 1, 2025
Ramiro Sanchez Director Jun 17, 2025

Recent Insider Transactions by Companies or Individuals for Rapport Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.